Please use this identifier to cite or link to this item:
Title: Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus
Authors: Beti Todorovska 
Caloska-Ivanova, Viktorija
Genadieva Dimitrova, Magdalena 
Trajkovska, Meri 
Popova Jovanovska, Rozalinda 
Grivceva-Stardelova, Kalina
Licoska-Josifovic, Fana
Andreevski, Vladimir 
Curakova Ristovska, Elena 
Joksimovic, Nenad
Keywords: hepatitis C virus infection,
pegylated interferon alpha,
sustained virological response
Issue Date: 31-May-2019
Publisher: ID Design 2012/Scientific Foundation SPIROSKI
Journal: Open Access Macedonian Journal of Medical Sciences 
Abstract: Chronic hepatitis C virus infection represents a more frequent cause of liver cirrhosis and hepatocellular carcinoma. Statins, inhibit HCV replication in vitro, enhance the antiviral effect of the already known antiviral drugs and reduce their resistance.
ISSN: 1857-9655
DOI: 10.3889/oamjms.2019.459
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
Trud objaven vo OAMJMS, maj 2019.pdf267.31 kBAdobe PDFView/Open
Show full item record

Page view(s)

checked on Oct 31, 2020


checked on Oct 31, 2020

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.